
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Acción · US75629V1044 · RXRX (XNAS)
5,57 USD
06.06.2025 23:59
Cotizaciones actuales de Recursion Pharmaceuticals, Inc. - Class A Common Stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
RXRX
|
USD
|
06.06.2025 23:59
|
5,57 USD
| 4,56 USD
+22,14 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 32,62 % | 33,25 % | -15,48 % | -30,38 % | -34,55 % | -69,06 % |
Perfil de la empresa para Recursion Pharmaceuticals, Inc. - Class A Common Stock Acción
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Datos de la empresa
Nombre Recursion Pharmaceuticals, Inc. - Class A Common Stock
Empresa Recursion Pharmaceuticals, Inc.
Símbolo RXRX
Sitio web
https://www.recursion.com
Mercado principal
NASDAQ

ISIN US75629V1044
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Dr. Christopher C. Gibson Ph.D.
Capitalización de mercado 2 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 0,8 T
Dirección 41 South Rio Grande Street, 84101 Salt Lake City
Fecha de OPV 2021-04-16
Símbolos de cotización
Nombre | Símbolo |
---|---|
NASDAQ | RXRX |
Otras acciones
Los inversores que tienen Recursion Pharmaceuticals, Inc. - Class A Common Stock también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.